Jeffrey J. Neil

ORCID: 0000-0002-8069-8175 · 1 paper in corpus

article 2021

O-132 Sustained efficacy and safety of relugolix combination therapy in women with endometriosis-associated pain: SPIRIT 52-week data

·doi:10.1093/humrep/deab126.057

Abstract Study question To assess the long-term (52-week) efficacy and safety of relugolix combination therapy (Relugolix-CT) in the treatment of endometriosis-associated pain. Summary answer Relugolix-CT demonstrated a sustained improvemen…